1-15 Anti-IL-13 Prospects in Asthma

Friday, 13 December 2013: 14:15 - 14:35
Great Lakes Grand Ballroom East (Westin - Michigan Avenue)

Sally Wenzel, MD , University of Pittsburgh, Division of Pulmonary, Allergy, and Critical Care Medicine, Pittsburgh, PA

Learning Objectives:
Illustrate the ability of Anti-IL-13 to inhibit Th2 mediated allergic reactions in asthma. 

Outline the effect of Anti-IL-13 on structural aspects of lung function. 

Identify which patients who receive Anti-IL-13 are more likely to make a positive response to the treatment.